Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)

Detalles Bibliográficos
Autores principales: Tamura, Yuichi, Ono, Tomohiko, Fukuda, Keiichi, Satoh, Toru, Sasayama, Shigetake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2013
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685701/
http://dx.doi.org/10.1007/s12325-013-0031-6
_version_ 1782273722692927488
author Tamura, Yuichi
Ono, Tomohiko
Fukuda, Keiichi
Satoh, Toru
Sasayama, Shigetake
author_facet Tamura, Yuichi
Ono, Tomohiko
Fukuda, Keiichi
Satoh, Toru
Sasayama, Shigetake
author_sort Tamura, Yuichi
collection PubMed
description
format Online
Article
Text
id pubmed-3685701
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-36857012013-06-25 Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4) Tamura, Yuichi Ono, Tomohiko Fukuda, Keiichi Satoh, Toru Sasayama, Shigetake Adv Ther Erratum Springer Healthcare 2013-05-25 2013-05 /pmc/articles/PMC3685701/ http://dx.doi.org/10.1007/s12325-013-0031-6 Text en © Springer Healthcare 2013
spellingShingle Erratum
Tamura, Yuichi
Ono, Tomohiko
Fukuda, Keiichi
Satoh, Toru
Sasayama, Shigetake
Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
title Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
title_full Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
title_fullStr Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
title_full_unstemmed Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
title_short Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
title_sort erratum to: evaluation of a new formulation of epoprostenol sodium in japanese patients with a pulmonary arterial hypertension (epitome4)
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685701/
http://dx.doi.org/10.1007/s12325-013-0031-6
work_keys_str_mv AT tamurayuichi erratumtoevaluationofanewformulationofepoprostenolsodiuminjapanesepatientswithapulmonaryarterialhypertensionepitome4
AT onotomohiko erratumtoevaluationofanewformulationofepoprostenolsodiuminjapanesepatientswithapulmonaryarterialhypertensionepitome4
AT fukudakeiichi erratumtoevaluationofanewformulationofepoprostenolsodiuminjapanesepatientswithapulmonaryarterialhypertensionepitome4
AT satohtoru erratumtoevaluationofanewformulationofepoprostenolsodiuminjapanesepatientswithapulmonaryarterialhypertensionepitome4
AT sasayamashigetake erratumtoevaluationofanewformulationofepoprostenolsodiuminjapanesepatientswithapulmonaryarterialhypertensionepitome4

Ejemplares similares